ASX - By Stock
|
NRZ |
Re:
Ann: Commercial Urea Production Contract Awarded
|
|
belfi
|
220 |
81K |
5 |
03/07/21 |
03/07/21 |
ASX - By Stock
|
220
|
81K
|
5
|
|
ASX - By Stock
|
NYR |
Re:
Ann: NYX-PCSK9i with Statin Achieves 65% Cholesterol Reduction
|
|
belfi
|
72 |
21K |
2 |
02/07/21 |
02/07/21 |
ASX - By Stock
|
72
|
21K
|
2
|
|
ASX - By Stock
|
NRZ |
Re:
Ann: Trading Halt
|
|
belfi
|
103 |
34K |
2 |
02/07/21 |
02/07/21 |
ASX - By Stock
|
103
|
34K
|
2
|
|
ASX - By Stock
|
NYR |
Re:
Ann: NYX-PCSK9i with Statin Achieves 65% Cholesterol Reduction
|
|
belfi
|
72 |
21K |
1 |
02/07/21 |
02/07/21 |
ASX - By Stock
|
72
|
21K
|
1
|
|
ASX - By Stock
|
NRZ |
Re:
Ann: Trading Halt
|
|
belfi
|
103 |
34K |
5 |
02/07/21 |
02/07/21 |
ASX - By Stock
|
103
|
34K
|
5
|
|
ASX - By Stock
|
NRZ |
Re:
Ann: Commercial Urea Production Contract Awarded
|
|
belfi
|
220 |
81K |
2 |
02/07/21 |
02/07/21 |
ASX - By Stock
|
220
|
81K
|
2
|
|
ASX - By Stock
|
NRZ |
Re:
Ann: Commercial Urea Production Contract Awarded
|
|
belfi
|
220 |
81K |
4 |
01/07/21 |
01/07/21 |
ASX - By Stock
|
220
|
81K
|
4
|
|
ASX - By Stock
|
NRZ |
Re:
Ann: Commercial Urea Production Contract Awarded
|
|
belfi
|
220 |
81K |
2 |
01/07/21 |
01/07/21 |
ASX - By Stock
|
220
|
81K
|
2
|
|
ASX - By Stock
|
NRZ |
Re:
Ann: Commercial Urea Production Contract Awarded
|
|
belfi
|
220 |
81K |
10 |
01/07/21 |
01/07/21 |
ASX - By Stock
|
220
|
81K
|
10
|
|
ASX - By Stock
|
NRZ |
Re:
Ann: Commercial Urea Production Contract Awarded
|
|
belfi
|
220 |
81K |
14 |
01/07/21 |
01/07/21 |
ASX - By Stock
|
220
|
81K
|
14
|
|
ASX - By Stock
|
NRZ |
Re:
Ann: Trading Halt
|
|
belfi
|
103 |
34K |
3 |
01/07/21 |
01/07/21 |
ASX - By Stock
|
103
|
34K
|
3
|
|
ASX - By Stock
|
NYR |
Re:
Ann: Change of Director's Interest Notice - CC
|
|
belfi
|
2 |
1.1K |
5 |
01/07/21 |
01/07/21 |
ASX - By Stock
|
2
|
1.1K
|
5
|
|
ASX - By Stock
|
NRZ |
Re:
Ann: Trading Halt
|
|
belfi
|
103 |
34K |
2 |
30/06/21 |
30/06/21 |
ASX - By Stock
|
103
|
34K
|
2
|
|
ASX - By Stock
|
NRZ |
Re:
Ann: Trading Halt
|
|
belfi
|
103 |
34K |
3 |
30/06/21 |
30/06/21 |
ASX - By Stock
|
103
|
34K
|
3
|
|
ASX - By Stock
|
NYR |
Re:
bull case
|
|
belfi
|
116 |
37K |
0 |
29/06/21 |
29/06/21 |
ASX - By Stock
|
116
|
37K
|
0
|
|
ASX - By Stock
|
NYR |
Re:
Ann: NYX-PCSK9i with Statin Achieves 65% Cholesterol Reduction
|
|
belfi
|
72 |
21K |
0 |
29/06/21 |
29/06/21 |
ASX - By Stock
|
72
|
21K
|
0
|
|
ASX - By Stock
|
NYR |
Re:
Ann: NYX-PCSK9i with Statin Achieves 65% Cholesterol Reduction
|
|
belfi
|
72 |
21K |
1 |
29/06/21 |
29/06/21 |
ASX - By Stock
|
72
|
21K
|
1
|
|
ASX - By Stock
|
NYR |
Re:
Ann: NYX-PCSK9i with Statin Achieves 65% Cholesterol Reduction
|
|
belfi
|
72 |
21K |
3 |
29/06/21 |
29/06/21 |
ASX - By Stock
|
72
|
21K
|
3
|
|
ASX - By Stock
|
NYR |
Re:
Ann: NYX-PCSK9i with Statin Achieves 65% Cholesterol Reduction
|
|
belfi
|
72 |
21K |
5 |
29/06/21 |
29/06/21 |
ASX - By Stock
|
72
|
21K
|
5
|
|
ASX - By Stock
|
NYR |
Re:
Ann: NYX-PCSK9i with Statin Achieves 65% Cholesterol Reduction
|
|
belfi
|
72 |
21K |
4 |
29/06/21 |
29/06/21 |
ASX - By Stock
|
72
|
21K
|
4
|
|
ASX - By Stock
|
NYR |
Re:
ddjdh
|
|
belfi
|
5 |
1.4K |
0 |
29/06/21 |
29/06/21 |
ASX - By Stock
|
5
|
1.4K
|
0
|
|
ASX - By Stock
|
NRZ |
Re:
Ann: $18 million Capital Raising
|
|
belfi
|
101 |
37K |
1 |
28/06/21 |
28/06/21 |
ASX - By Stock
|
101
|
37K
|
1
|
|
ASX - By Stock
|
NRZ |
Re:
Ann: $18 million Capital Raising
|
|
belfi
|
101 |
37K |
5 |
28/06/21 |
28/06/21 |
ASX - By Stock
|
101
|
37K
|
5
|
|
ASX - By Stock
|
NRZ |
Re:
Ann: $18 million Capital Raising
|
|
belfi
|
101 |
37K |
1 |
28/06/21 |
28/06/21 |
ASX - By Stock
|
101
|
37K
|
1
|
|
ASX - By Stock
|
NRZ |
Re:
Ann: $18 million Capital Raising
|
|
belfi
|
101 |
37K |
3 |
25/06/21 |
25/06/21 |
ASX - By Stock
|
101
|
37K
|
3
|
|
ASX - By Stock
|
NRZ |
Re:
Ann: $18 million Capital Raising
|
|
belfi
|
101 |
37K |
4 |
25/06/21 |
25/06/21 |
ASX - By Stock
|
101
|
37K
|
4
|
|
ASX - By Stock
|
NRZ |
Re:
Ann: $18 million Capital Raising
|
|
belfi
|
101 |
37K |
5 |
24/06/21 |
24/06/21 |
ASX - By Stock
|
101
|
37K
|
5
|
|
ASX - By Stock
|
NRZ |
Re:
Ann: $18 million Capital Raising
|
|
belfi
|
101 |
37K |
2 |
24/06/21 |
24/06/21 |
ASX - By Stock
|
101
|
37K
|
2
|
|
ASX - By Stock
|
NRZ |
eu-urea-a's eureka moment
|
|
belfi
|
1 |
961 |
5 |
23/06/21 |
23/06/21 |
ASX - By Stock
|
1
|
961
|
5
|
|
ASX - By Stock
|
NRZ |
Re:
Ann: $18 million Capital Raising
|
|
belfi
|
101 |
37K |
4 |
23/06/21 |
23/06/21 |
ASX - By Stock
|
101
|
37K
|
4
|
|
ASX - By Stock
|
NYR |
Re:
ddjdh
|
|
belfi
|
5 |
1.4K |
0 |
23/06/21 |
23/06/21 |
ASX - By Stock
|
5
|
1.4K
|
0
|
|
ASX - By Stock
|
NRZ |
Re:
Ann: $18 million Capital Raising
|
|
belfi
|
101 |
37K |
2 |
23/06/21 |
23/06/21 |
ASX - By Stock
|
101
|
37K
|
2
|
|
ASX - By Stock
|
NRZ |
Re:
Ann: $18 million Capital Raising
|
|
belfi
|
101 |
37K |
2 |
23/06/21 |
23/06/21 |
ASX - By Stock
|
101
|
37K
|
2
|
|
ASX - By Stock
|
NRZ |
Re:
Ann: $18 million Capital Raising
|
|
belfi
|
101 |
37K |
2 |
23/06/21 |
23/06/21 |
ASX - By Stock
|
101
|
37K
|
2
|
|
ASX - By Stock
|
NRZ |
Re:
Ann: Director Resignation and Appendix 3Z
|
|
belfi
|
4 |
2.0K |
1 |
23/06/21 |
23/06/21 |
ASX - By Stock
|
4
|
2.0K
|
1
|
|
ASX - By Stock
|
NRZ |
Re:
Ann: Director Resignation and Appendix 3Z
|
|
belfi
|
4 |
2.0K |
1 |
22/06/21 |
22/06/21 |
ASX - By Stock
|
4
|
2.0K
|
1
|
|
ASX - By Stock
|
NRZ |
Re:
Ann: $18 million Capital Raising
|
|
belfi
|
101 |
37K |
1 |
22/06/21 |
22/06/21 |
ASX - By Stock
|
101
|
37K
|
1
|
|
ASX - By Stock
|
NYR |
Re:
ddjdh
|
|
belfi
|
5 |
1.4K |
1 |
22/06/21 |
22/06/21 |
ASX - By Stock
|
5
|
1.4K
|
1
|
|
ASX - By Stock
|
NRZ |
Re:
Ann: $18 million Capital Raising
|
|
belfi
|
101 |
37K |
2 |
22/06/21 |
22/06/21 |
ASX - By Stock
|
101
|
37K
|
2
|
|
ASX - By Stock
|
NRZ |
Re:
Ann: $18 million Capital Raising
|
|
belfi
|
101 |
37K |
4 |
22/06/21 |
22/06/21 |
ASX - By Stock
|
101
|
37K
|
4
|
|
ASX - By Stock
|
NYR |
ddjdh
|
|
belfi
|
5 |
1.4K |
4 |
21/06/21 |
21/06/21 |
ASX - By Stock
|
5
|
1.4K
|
4
|
|
ASX - By Stock
|
NRZ |
Re:
Ann: $18 million Capital Raising
|
|
belfi
|
101 |
37K |
4 |
21/06/21 |
21/06/21 |
ASX - By Stock
|
101
|
37K
|
4
|
|
ASX - By Stock
|
NYR |
Re:
Ann: Results of Meeting
|
|
belfi
|
8 |
2.6K |
0 |
18/06/21 |
18/06/21 |
ASX - By Stock
|
8
|
2.6K
|
0
|
|
ASX - By Stock
|
NRZ |
Re:
Ann: $18 million Capital Raising
|
|
belfi
|
101 |
37K |
3 |
18/06/21 |
18/06/21 |
ASX - By Stock
|
101
|
37K
|
3
|
|
ASX - By Stock
|
NYR |
Re:
Ann: Results of Meeting
|
|
belfi
|
8 |
2.6K |
3 |
17/06/21 |
17/06/21 |
ASX - By Stock
|
8
|
2.6K
|
3
|
|
ASX - By Stock
|
NRZ |
Re:
Ann: Corporate Presentation
|
|
belfi
|
36 |
11K |
2 |
17/06/21 |
17/06/21 |
ASX - By Stock
|
36
|
11K
|
2
|
|
ASX - By Stock
|
NYR |
Re:
Ann: Results of Meeting
|
|
belfi
|
8 |
2.6K |
0 |
17/06/21 |
17/06/21 |
ASX - By Stock
|
8
|
2.6K
|
0
|
|
ASX - By Stock
|
NRZ |
Re:
Ann: Corporate Presentation
|
|
belfi
|
36 |
11K |
2 |
17/06/21 |
17/06/21 |
ASX - By Stock
|
36
|
11K
|
2
|
|
ASX - By Stock
|
NRZ |
Re:
Ann: Corporate Presentation
|
|
belfi
|
36 |
11K |
1 |
17/06/21 |
17/06/21 |
ASX - By Stock
|
36
|
11K
|
1
|
|
ASX - By Stock
|
NYR |
Re:
Ann: Improved Drug Candidate Selected for WRAIR Studies
|
|
belfi
|
4 |
2.0K |
1 |
17/06/21 |
17/06/21 |
ASX - By Stock
|
4
|
2.0K
|
1
|
|